Clinical Trials Logo

Delirium clinical trials

View clinical trials related to Delirium.

Filter by:

NCT ID: NCT02111447 Terminated - Clinical trials for Delirium on Emergence

Post Anesthesia Emergence and Behavioral Changes in Children Undergoing MRI

Start date: January 2014
Phase: Phase 4
Study type: Interventional

Children who receive general anesthesia may become agitated (emergence delirium) in the recovery period. This occurs more often after inhalational anesthetics, particularly sevoflurane and desflurane than after propofol. However, agitation after anesthesia in children may be difficult to distinguish from pain; accordingly studies are ideally designed during MRI to obviate the contribution of pain during emergence. Airway complications have been reported after LMA and isoflurane more commonly than with IV propofol and nasal prongs. Whether the airway complications were due to the LMA or the isoflurane was unclear. Therefore, this study was designed to study the incidence of 1. agitation after sevoflurane compared with IV propofol and 2. airway complications after LMA or nasal prongs.

NCT ID: NCT02109081 Terminated - Delirium Clinical Trials

Dexamethasone and Postoperative Delirium

Start date: April 2014
Phase: Phase 4
Study type: Interventional

Postoperative delirium is commonly observed in elderly patients in the postanesthesia care unit (PACU) and during the first 2-3 days following surgical procedures. This is an important clinical problem in the geriatric surgical patient; morbidity and mortality rates are significantly higher in patients who develop delirium. At the present time, the etiology of delirium has not been precisely defined. However, studies suggest that inflammation related to the surgical stress response is an important contributing factor in inducing neuroinflammation and subsequent cognitive dysfunction and delirium. Therefore it is possible that agents which attenuate perioperative inflammation may reduce the risk of the development of delirium following surgery. Dexamethasone is a potent corticosteroid that is used by anesthesiologists primarily as an antiemetic agent. Small doses of dexamethasone have also been demonstrated to significantly reduce the release of inflammatory markers after surgery. The anti-inflammatory effects of corticosteroids have the potential to beneficially impact neuroinflammation and the risk of developing postoperative delirium. The aim of this randomized, controlled, double-blinded investigation is to determine if dexamethasone, administered at induction of anesthesia, can decrease the incidence of delirium at the time of discharge from the PACU and during the first 2 days following surgery.

NCT ID: NCT02108795 Recruiting - Delirium Clinical Trials

The Effect of Remifentanil Infusion During Emergence on the Incidence of Emergence Delirium

Start date: April 2014
Phase: N/A
Study type: Interventional

The aim of the present study is to assess the effect of postoperative remifentanil infusion on the incidence of emergence agitation in preschool-aged children undergoing strabismus surgery with sevoflurane anaesthesia.

NCT ID: NCT02096068 Completed - Delirium Clinical Trials

Neuroprotection With Dexmedetomidine in Patients Undergoing Elective Cardiac or Abdominal Surgery (Neuprodex)

Start date: July 2014
Phase: Phase 4
Study type: Interventional

The drug Dexmedetomidine will be investigated in 72 patients (men and women) undergoing elective cardiac or abdominal surgery. The study medication will be administered perioperatively by intravenous infusion continuously (at the longest 48 h) to prevent/reduce the rate of Delirium and the incidence of postoperative cognitive deficit (POCD). A non-surgical control group of 15 ASA II/III- patients from Berlin and surrounding area is collected for measuring the learning experience during the cognitive testings. The participants are matched on age, education, and gender to the study patients. Cognitive testings are performed in patients of the study group (n= 72) and the control group (n= 15) to evaluate deficits in their cognitive areas (POCD (Postoperative cognitive deficit)) at three different time points up to three months.

NCT ID: NCT02086981 Completed - Delirium Clinical Trials

The DETEcT Study - Delirium in Elderly paTiEnts Admitted to Trauma

DETEcT
Start date: February 2014
Phase: N/A
Study type: Observational [Patient Registry]

Primary objectives are to define incidence and prevalence of Delirium in an elderly population admitted to the Department of Orthopedics and Traumatology and, in the postoperative phase, in the high Dependency Unit as well as to determine the presence of risk factors. Secondary objectives are to determine mean hospital stay, rates of complications as well as in-hospital mortality and at 1-3 and 12 months after discharge, functional recovery and cognitive outcomes at 1, 3 and 12 moths follow-up.

NCT ID: NCT02084394 Completed - Delirium Clinical Trials

Cerebral Blood Flow During CPB During Cardiac Surgery and the Presence of Post op Delirium

Start date: June 2013
Phase: Phase 4
Study type: Observational

Cardiac surgery is associated with multiple events and issues that increase risk for adverse postoperative neurological outcomes including postoperative cognitive dysfunction. The risk for postoperative delirium is generally thought to result from some previous health factors added to the susceptibility of the cardiac surgery process.

NCT ID: NCT02080169 Recruiting - Delirium Clinical Trials

Safety and Efficacy of Combined Sedation With Midazolam and Dexmedetomidine in ICU Patients

Start date: February 2014
Phase: Phase 4
Study type: Interventional

It is well known that ICU patients need sedation. Now no ideal sedation drug existed and every sedation drug has its advantage and disadvantage,so combined sedation may use the advantage and avoid the disadvantage of the sedation drug according to the patients'condition. Until now, there is rare study about the combined sedation or sequenced sedation of different sedation drug.The purpose of the study is to explore the value of combined sedation with midazolam and dexmedetomidine compared to single drug sedation in ICU, so as to seek an ideal sedation protocol that could reduce the cost of treatment,obtain the appropriate sedation not under sedation or over sedation,reduce the incidence of delirium, reduce the adverse event of sedation.

NCT ID: NCT02078583 Not yet recruiting - Delirium Clinical Trials

The Effect of Analgesia Based Sedation Protocol on Brain Function of Critical Care Patients

Start date: July 2014
Phase: Phase 4
Study type: Interventional

Benzodiazepines is a commonly uesd sedative medication,there are many reports that Benzodiazepines is associated with delirium ,but using of analgesia reduces benzodiazepines requirements .The purpose of this study is to determine whether analgesia based sedation protocol reduces the incident of delirium.

NCT ID: NCT02068170 Completed - Delirium Clinical Trials

Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

RISQ-PATH
Start date: February 2014
Phase: N/A
Study type: Observational

A prospective, observational study in a university hospital (UZ Leuven). Patients are included when they are treated with a potentional QT-prolonging drug: haloperidol for delirium, antibiotics (moxifloxacin, levofloxacin, azithromycin, clarithromycin, erythromycin, co-trimoxazole), antimycotics (ketoconazole, itraconazole, fluconazole, voriconazole), methadone, tacrolimus and oral oncolytics. An ECG is taken before the administration of the drug and 3-5 days after starting the drug to investigate the change in duration of the QTc-interval. Risk factors for developing QT-prolongation will be documented. Together with ECG2, an additional blood sample will be collected to measure the blood concentration of the drug.

NCT ID: NCT02056171 Terminated - Delirium Clinical Trials

Efficacy of Quetiapine for Pediatric Delirium

Start date: March 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This study is designed to assess the safety and efficacy of quetiapine as treatment for pediatric delirium.